These results demonstrate that immunization of HLA-B*0702 Ifnar1−/− mice with SARS-CoV-2 N104-113 peptide elicits an antigen-specific polyfunctional CD8+ T cell response and protects against SARS-CoV-2 infection and lung disease. Here, CD8A is linked to lung disorder.